Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Annals of Surgical Oncology|January 6, 2026
The Cost of Progress that Pays OffAlice Cattelani, Alessandro GiardinoGastrointestinal Endoscopy Clinics of North America|May 28, 2023
Risk Models for Pancreatic Cyst DiagnosisAlice Cattelani, Giampaolo Perri, Giovanni Marchegiani, et al.Updates in Surgery|April 12, 2023
Routes of nutrition for pancreatic fistula after pancreatoduodenectomy: a prospective snapshot study identifies the need for therapy standardizationGiampaolo Perri, Giovanni Marchegiani, Elisa Romandini, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 15, 2023
No role for protease inhibitors as a mitigation strategy for postpancreatectomy acute pancreatitis (PPAP): Propensity score matching analysisElisa Bannone, Alessandra Pulvirenti, Giovanni Marchegiani, et al.Surgery|May 31, 2022
Postoperative serum hyperamylasemia (POH) predicts additional morbidity after pancreatoduodenectomy: It is not all about pancreatic fistulaElisa Bannone, Giovanni Marchegiani, Giampaolo Perri, et al.Annals of Surgical Oncology|January 29, 2024
Adjuvant Therapy After Upfront Resection of Resectable Pancreatic Cancer: Patterns of Omission and Use-A Prospective Real-Life StudySalvatore Paiella, Giuseppe Malleo, Gabriella Lionetto, et al.BJS Open|June 26, 2026
Drain management after pancreatoduodenectomy: risk-stratified dynamic algorithmGiampaolo Perri, Elisa Bannone, Isabella Frigerio, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 17, 2026
Trans-anastomotic stent does not impact the predictive value of drain fluid amylase after pancreatoduodenectomyGiampaolo Perri, Aya Maekawa, Isabella Frigerio, et al.Journal of Clinical Medicine|February 13, 2026
From Open to Robot-Assisted Pancreatoduodenectomy: What RCTs Really ShowAlice Cattelani, Roberto M Montorsi, Alessio Marchetti, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 6, 2025
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohortLuca Landoni, Salvatore Paiella, Alessio Marchetti, et al.Pageof 2